Institutional response to FDA warning on aprotinin and impact on outcomes.

导出 LinkOut

翻译打印收藏纠错

第一作者： M,Swaminathan

第一单位： Division of Cardiothoracic Anesthesiology and Critical Care Medicine,Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.

作者： M,Swaminathan ^[1] ; M,Stuart ; G C,Hughes ; J,Jaggers ; S E,Hill ; C A,Milano ; E,Bennett-Guerrero ; M,Stafford-Smith

作者单位： Division of Cardiothoracic Anesthesiology and Critical Care Medicine,Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA. ^[1]

关键词 Anesthesia Aprotinin Bleeding Cardiac surgery Guidelines

PMID 23439283

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

HSR proceedings in intensive care & cardiovascular anesthesia

2009年1卷1期

30-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Institutional response to FDA warning on aprotinin and impact on outcomes.

HSR proceedings in intensive care & cardiovascular anesthesia

相似文献

HSR proceedings in intensive care & cardiovascular anesthesia

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Institutional response to FDA warning on aprotinin and impact on outcomes.

HSR proceedings in intensive care & cardiovascular anesthesia

相似文献

HSR proceedings in intensive care & cardiovascular anesthesia

相关期刊

检索历史清除